Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer

Cancer Science

Volumn 100, Issue 9, 2009, Pages 1767-1771

  Christgen, Matthias ^a   Christgen, Henriette ^a   Heil, Charlotte ^a   Krech, Till ^a   Länger, Florian ^a   Kreipe, Hans ^a   Lehmann, Ulrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; CD82 PROTEIN, HUMAN; ESR1 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; TUMOR MARKER;

ARTICLE; BREAST TUMOR; CANCER INVASION; CANCER STAGING; DISEASE COURSE; DNA MICROARRAY; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; DISEASE PROGRESSION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; KANGAI-1 PROTEIN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 70149103089     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01231.x     Document Type: Article

References (25)

1. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003; 4: 51-62.
2. Debies MT, Welch DR. Genetic basis of human breast cancer metastasis. J Mammary Gland Biol Neoplasia 2001; 6: 441-51.
3. Dong JT, Lamb PW, Rinker-Schaeffer CW et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995; 268: 884-6.
4. Kim JH, Kim B, Cai L et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 2005; 434:921-6.
5. Bandyopadhyay S, Zhan R, Chaudhuri A et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006; 12: 933-8.
6. Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 2001; 61: 5284-8.
7. Sridhar SC, Miranti CK. Tetraspanin KAI1/CD82 suppresses invasion byinhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 2006; 25: 2367-78.
8. Ueda T, Ichikawa T, Tamaru J et al. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Am J Pathol 1996; 149:1435-40.
9. Bouras T, Frauman AG. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade. J Pathol 1999; 188: 382-8.
10. Dong JT, Suzuki H, Pin SS et al. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 1996; 56: 4387-90.
11. White A, Lamb PW, Barrett JC. Frequent downregulation of the KAI1 (CD82) metastasis suppressor protein in human cancer cell lines. Oncogene 1998; 16: 3143-9.
12. Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL. KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997; 119: 149-55.
13. Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Clin Cancer Res 2005; 11: 4357-64.
14. Christgen M, Bruchhardt H, Ballmaier M et al. KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer. Int J Cancer 2008; 123: 2239-46.
15. Callagy GM, Pharoah PD, Pinder SE et al. Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index. Clin Cancer Res 2006; 12: 2468-75.
16. Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5: 591-602.
17. Koenders PG, Beex LV, Langens R, Kloppenborg PW, Smals AG, Benraad TJ. Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. Breast Cancer Res Treat 1991; 18: 27-32.
18. James JJ, Evans AJ, Pinder SE et al. Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features. Br J Cancer 2003; 89: 660-5.
19. Gaedcke J, Traub F, Milde S et al. Predominance of the basal type and HER- 2/neu type in brain metastasis from breast cancer. Mod Pathol 2007; 20: 864-70.
20. Stark AM, Tongers K, Maass N, Mehdorn HM, Held-Feindt J. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 2005; 131: 191-8.
21. Christgen M, Ballmaier M, Bruchhardt H, von Wasielewski R, Kreipe H, Lehmann U. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Mol Cell Biochem 2007; 306: 201-12.
22. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003; 100: 15901-5.
23. Takaoka A, Hinoda Y, Sato S et al. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells. Jpn J Cancer Res 1998; 89: 397-404.
24. Lee JH, Park SR, Chay KO et al. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 2004; 64: 4235-43.
25. Yang XH, Richardson AL, Torres-Arzayus MI et al. CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 2008; 68: 3204-13.